Articles: trauma.
-
We conducted an audit of paediatric trauma admissions to QECH, Blantyre, in September 2003. There were 107 trauma cases representing 8.8% of all paediatric admissions and mean age was 6 years. The commonest cause of trauma was falls (42.9%) followed by burns (31.8%) and road traffic accidents (14.9%). ⋯ Most (52.6%) children were brought into hospital within 24 hours of injury while 26.3% came in between 24 hours and 48 hours and 21.1% after 48 hours or more. Death occurred in 7.5% of cases. The mean number of days in hospital was 8.9 days.
-
ANZ journal of surgery · Mar 2005
Nerve injuries in orthopaedics: is there anything more we need to tell our patients?
Perioperative nerve injuries are uncommon in most elective orthopaedic operations. However, despite the low incidence, patients tend to be most unforgiving when this complication occurs. The present study aims to determine the adequacy of the consent process, and seeks to identify deficiencies. ⋯ The need to adequately provide informed consent for nerve dysfunction is present. The present study demonstrates a dilemma between the provision of information and the creation of fear in the minds of recipients of surgery.
-
J Hand Surg Eur Vol · Feb 2005
Biography Historical Article Classical Article"Tingling" signs with peripheral nerve injuries. 1915.
-
Anemia is common in acute critically ill patients. Although blood loss, either by trauma, surgery, phlebotomies or gastrointestinal bleeding, may play a role, the anemia in these patients bears many similarities to the anemia characteristic of chronic disease. Serum iron is low with a high concentration of ferritin and low-to-normal transferrin and serum transferrin receptor levels. ⋯ In individual situations, such as in cardiovascular and cancer patients, higher thresholds may be appropriate. The administration of rh-EPO is an alternative to reduce the need for red blood cell transfusions and to avoid transfusion-related complications. Although its efficacy has been shown, questions regarding cost-benefit, dose regimen and clinical outcomes need to be answered before its large-scale use can be recommended.